TrialClinical and translational science2024

Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring FGFR2 gene amplification.

Jiajia Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.